The once-a-day Wegovy weight loss pill is now available to buy privately from High Street and online pharmacies in the UK, offering an alternative for those who dread needles but desperate to shed pounds. The tablet contains the same active ingredient – semaglutide – as the Wegovy injections that have already transformed the obesity treatment landscape, and trials show both are similarly effective. But unlike the weekly jab, which must be stored in the fridge and can be taken at any time, the pill demands a strict regimen: it must be taken on an empty stomach after at least eight hours without food, swallowed whole with no more than 120ml of plain water, and then the patient must wait 30 minutes before eating or drinking anything else. Ideally taken at the same time each day, the pill is meant to be used alongside a healthy diet and increased physical activity. If a dose is missed, the advice is to skip it and resume the next day as scheduled.
Eligibility for the pill mirrors that of the injection: a body mass index of 30 or above – generally considered obese – or a BMI of 27 to 30 if the person also has weight-related health conditions such as type 2 diabetes or high blood pressure. A consultation, either online or face-to-face, is required to ensure the treatment is suitable. Several High Street and online pharmacies say they will have stock soon, with some already inviting people to join waiting or mailing lists to be kept informed.
“Wegovy weight loss pill now available privately in UK pharmacies”
Semaglutide works by mimicking a hormone called GLP-1, which is released from the intestine after eating and acts on receptors in the brain that control appetite, making people feel fuller, less hungry and less likely to crave food. Very common side effects include stomach problems: feeling sick, vomiting, constipation and diarrhoea. The injections can also cause skin redness, itching or mild swelling at the injection site. More rarely, people on either form may experience stomach pain, headaches or tiredness, and serious complications such as low blood sugar, pancreatitis or severe allergic reactions have been reported. The patient information leaflet should be consulted for full details.
Although the pill is now available privately, it is not yet offered on the NHS. For those who dislike needles, the tablet may be a better option – but the need to fast for eight hours before each dose could make the once-weekly injection more convenient for some. As demand surges, the choice between pill and jab may come down to lifestyle as much as weight-loss goals.